A first-in-human Phase 1/1b randomized trial evaluating the safety and immunogenicity of a respiratory syncytial virus (RSV) virus-like particle subunit vaccine (IVX-121) in healthy young and older adults

Bron
Human vaccines & immunotherapeutics - ISSN 2164-5515-22:1 (2026) p. 1-19
Auteur(s)

Poliopolis : pushing boundaries of scientific innovations for disease eradication

Bron
Future microbiology - ISSN 1746-0913-14:15 (2019) p. 1321-1330
Auteur(s)

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

Bron
The lancet : international edition - ISSN 0140-6736-394:10193 (2019) p. 148-158
Auteur(s)
    Pierre van Damme, Ilse De Coster, Ananda S. Bandyopadhyay, Hilde Revets, Kanchanamala Withanage, Philippe De Smedt, Leen Suykens, M. Steven Oberste, William C. Weldon, Sue Ann Costa-Clemens, Ralf Clemens, John Modlin, Amy J. Weiner, Andrew J. Macadam, Raul Andino, Olen M. Kew, Jennifer L. Konopka-Anstadt, Cara C. Burns, John Konz, Rahnuma Wahid, Christopher Gast